E Fund Management (HK)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.9K Buy
2,154
+816
+61% +$21.3K 0.02% 192
2026
Q1
$37.6K Buy
1,338
+1,143
+586% +$30.4K 0.02% 179
2025
Q4
$5.2K Buy
195
+160
+457% +$4.04K ﹤0.01% 234
2025
Q3
$892 Buy
+35
New +$864 ﹤0.01% 213

Other funds holding PFE

E Fund Management (HK)'s PFE Position: Q2 2026 in Review

E Fund Management (HK) increased its Pfizer (PFE) stake by 61% in Q2 2026, buying an estimated $21.3K and bringing the position to 2,154 shares worth $51.9K. The position accounts for 0.02% of the portfolio, ranked #192.

E Fund Management (HK) first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. 1,224 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • E Fund Management (HK) held 2,154 shares of Pfizer worth $51.9K as of Q2 2026.
  • E Fund Management (HK) bought 816 Pfizer shares in Q2 2026, an estimated $21.3K.
  • Pfizer made up 0.02% of E Fund Management (HK)'s portfolio in Q2 2026, its #192 holding.
  • E Fund Management (HK) first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • 1,224 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.